Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Breast Cancer Research and Treatment
|
October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases
Dmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
BMC Medical Genomics
|
August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden, James Storhoff, Torsten Nielsen, et al.
Human Pathology
|
June 21, 2019
Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers
Zhouchunyang Xia, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Breast Cancer Research and Treatment
|
February 6, 2016
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
Brandon S Sheffield, Zuzana Kos, Karama Asleh-Aburaya, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
Amy Jamieson, Marcel Grube, Felix Kommoss, et al.
Nature Communications
|
June 26, 2024
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers
Amirali Darbandsari, Hossein Farahani, Maryam Asadi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 26, 2024
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
Amy Jamieson, Marcel Grube, Felix Kommoss, et al.
The American Journal of Surgical Pathology
|
September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement
Cheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
Carmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Supervised risk predictor of breast cancer based on intrinsic subtypes
Joel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Breast Cancer Research and Treatment
|
October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases
Dmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
BMC Medical Genomics
|
August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden, James Storhoff, Torsten Nielsen, et al.
Human Pathology
|
June 21, 2019
Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers
Zhouchunyang Xia, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Breast Cancer Research and Treatment
|
February 6, 2016
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
Brandon S Sheffield, Zuzana Kos, Karama Asleh-Aburaya, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
Amy Jamieson, Marcel Grube, Felix Kommoss, et al.
Nature Communications
|
June 26, 2024
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers
Amirali Darbandsari, Hossein Farahani, Maryam Asadi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 26, 2024
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
Amy Jamieson, Marcel Grube, Felix Kommoss, et al.
The American Journal of Surgical Pathology
|
September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement
Cheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
Carmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Supervised risk predictor of breast cancer based on intrinsic subtypes
Joel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Page
of 13